Medicine / D-0804-2026
U.S. Food and Drug AdministrationD-0804-2026
Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured…
Class II Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3
Recalling firm
Apotex Corp.
Reason for recall
Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
Where it went
US Nationwide.
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.